<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34862236</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1473-4893</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical medicine (London, England)</Title>
          <ISOAbbreviation>Clin Med (Lond)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transverse myelitis: a diagnostic challenge.</ArticleTitle>
        <Pagination>
          <StartPage>e682</StartPage>
          <MedlinePgn>e682</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.7861/clinmed.Let.21.6.1</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abkur</LastName>
            <ForeName>Tarig</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Senior specialist registrar in neurology, Southmead Hospital, Bristol, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Saeed</LastName>
            <ForeName>Mamoun</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Senior specialist registrar in neurology, Chelsea and Westminster Hospital, London, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Med (Lond)</MedlineTA>
        <NlmUniqueID>101092853</NlmUniqueID>
        <ISSNLinking>1470-2118</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Clin Med (Lond). 2021 Sep;21(5):e535-e538</RefSource>
          <PMID Version="1">34507942</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009188" MajorTopicYN="Y">Myelitis, Transverse</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34862236</ArticleId>
        <ArticleId IdType="pmc">PMC8806297</ArticleId>
        <ArticleId IdType="doi">10.7861/clinmed.Let.21.6.1</ArticleId>
        <ArticleId IdType="pii">21/6/e682</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med
2021;21:e535–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8439525</ArticleId>
            <ArticleId IdType="pubmed">34507942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonhard SE, Mandarakas MR, Gondim FAA, et al. . Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol
2019;15:671–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6821638</ArticleId>
            <ArticleId IdType="pubmed">31541214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Machado PM, Lawson-Tovey S, Hyrich K, et al. . LB0002 COVID-19 vaccine safety in patients with rheumatic and musculoskeletal disease. Annals of the Rheumatic Diseases
2021;80:199–200.</Citation>
        </Reference>
        <Reference>
          <Citation>Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B. Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine. Kidney Int
2021;100:459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8191285</ArticleId>
            <ArticleId IdType="pubmed">34119512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conticini E, d'Alessandro M, Bergantini L, et al. . Relapse of microscopic polyangiitis after vaccination against COVID-19: A case report. J Med Virol
2021;93:6439–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8426895</ArticleId>
            <ArticleId IdType="pubmed">34251683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis
2003;20:118–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12870721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist
2009;15:108–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19276791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nordström S, Andersson B, Malmeström C. Cerebrospinal fluid CD4+ /CD8+ ratio in diagnosing neurosarcoidosis. Acta Neurol Scand
2020;142:480–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32533774</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
